The Applications and Challenges of the Development of In Vitro Tumor Microenvironment Chips

The tumor microenvironment (TME) plays a critical, yet mechanistically elusive role in tumor development and progression, as well as drug resistance. To better understand the pathophysiology of the complex TME, a reductionist approach has been employed to create in vitro microfluidic models called tumor chips . Herein, we review the fabrication processes, applications, and limitations of the tumor chips currently under development for use in cancer research. Tumor chips afford capabilities for real-time observation, precise control of microenvironment factors (e.g. stromal and cellular components), and application of physiologically relevant fluid shear stresses and perturbations. Applications for tumor chips include drug screening and toxicity testing, assessment of drug delivery modalities, and studies of transport and interactions of immune cells and circulating tumor cells with primary tumor sites. The utility of tumor chips is currently limited by the ability to recapitulate the nuances of tumor physiology, including extracellular matrix composition and stiffness, heterogeneity of cellular components, hypoxic gradients, and inclusion of blood cells and the coagulome in the blood microenvironment. Overcoming these challenges and improving the physiological relevance of in vitro tumor models could provide powerful testing platforms in cancer research and decrease the need for animal and clinical studies.

Automated summary

The tumor microenvironment (TME) is crucial in tumor development and drug resistance, but its mechanisms are elusive. In vitro microfluidic models called tumor chips have been developed to study the complex TME. Tumor chips allow real-time observation, precise control of microenvironment factors, and application of relevant stresses and perturbations. Their applications include drug screening, drug delivery assessment, and studies of immune cell and circulating tumor cell interactions. However, challenges remain in recapitulating tumor physiology. Overcoming these challenges could provide powerful testing platforms in cancer research.